Bae et al., 2014 - Google Patents
Hierarchical cluster analysis of progression patterns in open-angle glaucoma patients with medical treatmentBae et al., 2014
View HTML- Document ID
- 5757957479542606255
- Author
- Bae H
- Rho S
- Lee H
- Lee N
- Hong S
- Seong G
- Sung K
- Kim C
- Publication year
- Publication venue
- Investigative Ophthalmology & Visual Science
External Links
Snippet
Purpose.: To classify medically treated open-angle glaucoma (OAG) by the pattern of progression using hierarchical cluster analysis, and to determine OAG progression characteristics by comparing clusters. Methods.: Ninety-five eyes of 95 OAG patients who …
- 206010030348 Open angle glaucoma 0 title abstract description 57
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/102—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/18—Arrangement of plural eye-testing or -examining apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/02—Subjective types, i.e. testing apparatus requiring the active assistance of the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Danesh-Meyer et al. | In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors | |
| Medeiros et al. | Influence of disease severity and optic disc size on the diagnostic performance of imaging instruments in glaucoma | |
| Leite et al. | Effect of disease severity on the performance of Cirrus spectral-domain OCT for glaucoma diagnosis | |
| Medeiros et al. | Detection of progressive retinal nerve fiber layer loss in glaucoma using scanning laser polarimetry with variable corneal compensation | |
| Ferreras et al. | Mapping standard automated perimetry to the peripapillary retinal nerve fiber layer in glaucoma | |
| Medeiros et al. | Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical models | |
| Mowatt et al. | Screening tests for detecting open-angle glaucoma: systematic review and meta-analysis | |
| Kankipati et al. | The post-illumination pupil response is reduced in glaucoma patients | |
| Bowd et al. | Structure–function relationships using confocal scanning laser ophthalmoscopy, optical coherence tomography, and scanning laser polarimetry | |
| Cheng et al. | The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis | |
| Nousome et al. | Retinal nerve fiber layer thickness in healthy eyes of black, Chinese, and Latino Americans: a population-based multiethnic study | |
| Wang et al. | Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening | |
| Medeiros et al. | Incorporating risk factors to improve the assessment of rates of glaucomatous progression | |
| Yoo et al. | Artificial neural network approach for differentiating open-angle glaucoma from glaucoma suspect without a visual field test | |
| Asaoka et al. | Identifying “preperimetric” glaucoma in standard automated perimetry visual fields | |
| Alencar et al. | The role of standard automated perimetry and newer functional methods for glaucoma diagnosis and follow-up | |
| De Moraes et al. | Association of macular visual field measurements with glaucoma staging systems | |
| Zhang et al. | Comparison of several parameters in two optical coherence tomography systems for detecting glaucomatous defects in high myopia | |
| Nieves-Moreno et al. | New normative database of inner macular layer thickness measured by Spectralis OCT used as reference standard for glaucoma detection | |
| Hirasawa et al. | Clustering visual field test points based on rates of progression to improve the prediction of future damage | |
| Wendel et al. | Multimodal high-resolution imaging in retinitis pigmentosa: a comparison between optoretinography, cone density, and visual sensitivity | |
| Leung et al. | American Chinese glaucoma imaging study: a comparison of the optic disc and retinal nerve fiber layer in detecting glaucomatous damage | |
| Bae et al. | Hierarchical cluster analysis of progression patterns in open-angle glaucoma patients with medical treatment | |
| Sawada et al. | Progression to legal blindness in patients with normal tension glaucoma: hospital-based study | |
| Solli et al. | Archetypal analysis reveals quantifiable patterns of visual field loss in optic neuritis |